Bank Of New York Mellon Corp Meridian Bioscience Inc Transaction History

Bank Of New York Mellon Corp

$521 Trillion
Q1 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$31.15 - $33.39 $12.8 Million - $13.7 Million	409,347 New	409,347 $13.6 Million
Q3 2022 Nov 14, 2022	SELL	$30.9 - $33.55 $134,106 - $145,607	-4,340 Reduced 0.98%	438,342 $13.8 Million
Q2 2022 Aug 15, 2022	SELL	$23.75 - $31.69 $158,460 - $211,435	-6,672 Reduced 1.48%	442,682 $13.5 Million
Q1 2022 May 11, 2022	SELL	$19.97 - $26.94 $4,013 - $5,414	-201 Reduced 0.04%	449,354 $11.7 Million
Q4 2021 Feb 11, 2022	SELL	$17.46 - $21.61 $246,762 - $305,414	-14,133 Reduced 3.05%	449,555 $9.17 Million

Q3 2021 Nov 12, 2021	SELL	$17.35 - $22.5 $189,895 - $246,262	-10,945 Reduced 2.31%	463,688 $8.92 Million
Q2 2021 Aug 11, 2021	SELL	$18.01 - $28.32 $473,176 - $744,051	-26,273 Reduced 5.25%	474,633 $10.5 Million
Q1 2021 May 13, 2021	SELL	$19.76 - $29.89 $158,435 - $239,658	-8,018 Reduced 1.58%	500,906 $13.1 Million
Q4 2020 Feb 09, 2021	SELL	$15.73 - $21.66 $106,319 - $146,399	-6,759 Reduced 1.31%	508,924 $9.51 Million
Q3 2020 Nov 12, 2020	SELL	$13.54 - $26.41 $114,196 - $222,741	-8,434 Reduced 1.61%	515,683 $8.76 Million
Q2 2020 Aug 12, 2020	SELL	$7.84 - $23.29 $105,941 - $314,717	-13,513 Reduced 2.51%	524,117 $12.2 Million
Q1 2020 May 06, 2020	SELL	$5.57 - $11.5 $96,399 - $199,030	-17,307 Reduced 3.12%	537,630 $4.52 Million
Q4 2019 Feb 14, 2020	BUY	$7.9 - $10.14 $302,475 - $388,240	38,288 Added 7.41%	554,937 $5.42 Million
Q3 2019 Nov 07, 2019	SELL	$9.17 - $12.01 $244,912 - $320,763	-26,708 Reduced 4.92%	516,649 $4.9 Million
Q2 2019 Aug 12, 2019	SELL	$10.88 - $17.6 $1.73 Million - $2.8 Million	-158,915 Reduced 22.63%	543,357 $6.46 Million
Q1 2019 May 14, 2019	BUY	$15.51 - $17.61 $122,404 - $138,978	7,892 Added 1.14%	702,272 $12.4 Million
Q4 2018 Feb 11, 2019	SELL	$14.52 - $19.72 $1.85 Million - $2.51 Million	-127,082 Reduced 15.47%	694,380 $12.1 Million
Q3 2018 Nov 09, 2018	BUY	$14.85 - $16.35 $142,782 - $157,205	9,615 Added 1.18%	821,462 $0
Q2 2018 Aug 06, 2018	BUY	$13.8 - $16.8 $192,330 - $234,141	13,937 Added 1.75%	811,847 $12.9 Million
Q1 2018 May 15, 2018	BUY	$13.8 - $16.2 $55,959 - $65,691	4,055 Added 0.51%	797,910 $11.3 Million
Q4 2017 Feb 09, 2018	BUY	$13.55 - $15.8 $10.8 Million - $12.5 Million	793,855	793,855 $11.1 Million

Others Institutions Holding VIVO

# of Institutions

Shares Held

113K

Call Options Held

Put Options Held

View Full List

About MERIDIAN BIOSCIENCE INC

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

More about VIVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account